| 46.26 |  -0.91 / -1.93% |
Data as of 4:03pm ET | Day’s Change |
| 46.30 |  +0.04 / +0.09% |
Volume: 53,000 |
| Excerpt From My Daily Journal Entry 7:52pm / StockTwits | Court stops EU regulator releasing drug trial data Apr 30 / FT.com |
| 10 ASCO '13 Abstracts You Can Read Right Now May 15 / TheStreet.com | Apple launches biggest US corporate bond Apr 30 / FT.com |
| Merck's Liptruzet Approved in the US - Analyst Blog May 07 / Zacks.com | US pharma: spot the difference Apr 29 / FT.com |
| Previous close | 47.17 |
| Today’s open | 47.12 |
| Day’s range | 46.07 - 47.14 |
| Volume | 3,537,860 |
| Average volume (3 months) | 6,761,958 |
| Market cap | $74.7B |
| Dividend yield | 3.46% |
| Earnings growth (last year) | -17.82% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | +11.55% |
| P/E ratio | 11.7 |
| Price/Sales | -- |
| Price/Book | 33.43 |
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk A/S | -0.31 | -0.18% |
| BMYBristol-Myers Squibb... | +0.46 | +1.06% |
| AZNAstraZeneca PLC | -0.06 | -0.12% |
| LLYEli Lilly and Co | -0.88 | -1.57% |
| Next reporting date | August 28, 2013 |
| EPS forecast (this quarter) | $0.79 |
| Annual revenue (last year) | $17.4B |
| Annual profit (last year) | $3.4B |
| Net profit margin | 19.68% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman & Chief Executive Officer Richard A. Gonzalez |
Senior Vice President- Operations Azita Saleki-Gerhardt, PhD |
Corporate headquarters North Chicago, Illinois |
.
